Gonadal Function after Busulfan Compared with Treosulfan in Children and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell Transplant

Author(s):
Faraci, M.; Diesch, T.; Labopin, M.; Dalissier, A.; Lankester, A.; Gennery, A.; Sundin, M.; Uckan-Cetinkaya, D.; Bierings, M.; Peters, A.M.J.; Garwer, M.; Schulz, A.; Michel, G.; Giorgiani, G.; Gruhn, B.; Locatelli, F.; Giardino, S.; Uyttebroeck, A.; Rialland, F.; Itala-Remes, M.; Dreger, P.; Shaw, P.J.; Bordon, V.; Schlegel, P.G.; Mellgren, K.; Moraleda, J.M.; Patrick, K.; Schneider, P.; Jubert, C.; Lawitschka, A.; Salooja, N.; Basak, G.W.; Corbacioglu, S.; Duarte, R.; Bader, P.; Pediat Transplant Complications Wo
Published
2019
Publication type
Article / Letter to editor
Gonadal damageBusulfanTreosulfanPubertal stage
Date issued
2019-09-30
Language
English
Is part of
Biology of Blood and Marrow Transplantation (2019), Vol. 25, no. 9, p. 1786-1791
hdl
1887/120450
doi
10.1016/j.bbmt.2019.05.005